No effect of bezafibrate in patients with CPTII and VLCAD deficiencies
- 21 October 2014
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 38 (2) , 373-374
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Bezafibrate in skeletal muscle fatty acid oxidation disordersNeurology, 2014
- Bezafibrate for an Inborn Mitochondrial Beta-Oxidation DefectNew England Journal of Medicine, 2009
- PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disordersJournal of Inherited Metabolic Disease, 2008
- Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiencyNeurology, 2003
- Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucoseNeurology, 2002